MD Biosciences成立于1991年，總部位于瑞士，在美國、加拿大和英國設(shè)有辦事處。旗下MD Bioproducts部門主要產(chǎn)品涉及腫瘤、心血管、細(xì)胞培養(yǎng)、內(nèi)分泌、炎癥、代謝疾病、神經(jīng)科學(xué)、疼痛、腎臟/肝臟功能等領(lǐng)域。產(chǎn)品包括抗體 (軟骨蛋白聚糖、膠原蛋白、激素、神經(jīng)藥物)、細(xì)胞培養(yǎng)相關(guān)試劑 (膠原蛋白、細(xì)胞增殖檢測、支原體PCR檢測)、疾病誘導(dǎo)試劑 (關(guān)節(jié)炎誘導(dǎo)抗體混合、弗氏佐劑、膠原蛋白II等)、ELISA試劑盒、同型對照、天然蛋白以及重組蛋白。

BioProductsMD is the world leader in producing Human PEDF kits and reagents for research labs. Integrating BioProductsMD with the XpressBio team will expand the product offerings and solutions that our company can offer to the research community.

Human Pigment epithelium-derived factor (PEDF) is a multipotent neurotrophic factor with potent activity both in the central nervous system and in the retina. To date, PEDF is the most potent angiogenic inhibitor found in the mammalian ocular compartment. Interestingly, recent studies have shown that decreased ocular levels of PEDF are associated with diabetic retinopathy and other neuroretinal dystrophic diseases. In addition, the neurotropic and anti-angiogenic properties of PEDF suggest this protein is of potential therapeutic value for control of neovascularization associated with tumor growth.